Inspire Investing’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$476K Sell
2,478
-183
-7% -$29.8K 0.02% 987
2026
Q2
$363K Buy
+2,661
New +$327K 0.01% 984
2023
Q3
– Sell
-9,320
Closed -$1.32M – 868
2023
Q2
$1.32M Buy
9,320
+444
+5% +$71.2K 0.16% 154
2023
Q1
$1.49M Buy
8,876
+713
+9% +$127K 0.19% 112
2022
Q4
$1.38M Buy
8,163
+1,320
+19% +$239K 0.18% 121
2022
Q3
$1.28M Buy
+6,843
New +$1.44M 0.18% 112
2021
Q2
– Sell
-2,948
Closed -$573K – 614
2021
Q1
$573K Buy
2,948
+1,198
+68% +$246K 0.09% 231
2020
Q4
$335K Buy
+1,750
New +$318K 0.07% 383

Other funds holding RGEN

Inspire Investing's RGEN Position: Q3 2026 in Review

Inspire Investing reduced its Repligen (RGEN) stake by 6.9% in Q3 2026, selling an estimated $29.8K and leaving 2,478 shares worth $476K. The position accounts for 0.02% of the portfolio, ranked #987.

Inspire Investing first reported a position in RGEN in Q4 2020 and has held it in 8 quarters since. The position peaked at $1.49M in Q1 2023. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Inspire Investing held 2,478 shares of Repligen worth $476K as of Q3 2026.
  • Inspire Investing sold 183 Repligen shares in Q3 2026, an estimated $29.8K.
  • Repligen made up 0.02% of Inspire Investing's portfolio in Q3 2026, its #987 holding.
  • Inspire Investing first reported a position in Repligen in Q4 2020 and has held it in 8 quarters since.
  • Inspire Investing's Repligen position peaked at $1.49M in Q1 2023.
  • 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.